• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    141.77 Up 4.04(2.93%) May 27, 4:00PM EDT
    |After Hours : 139.01 Down 2.76 (1.95%) May 27, 7:45PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 445   446   445   446  
    Cost of Revenue -   -   -   -  
    Gross Profit 445   446   445   446  
    Operating Expenses
    Research Development37,413  44,446  27,487  28,294  
    Selling General and Administrative90,432  44,891  24,742  20,974  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (127,400) (88,891) (51,784) (48,823)
    Income from Continuing Operations
    Total Other Income/Expenses Net726  637  889  929  
    Earnings Before Interest And Taxes(126,674)(88,254)(50,895)(47,894)
    Interest Expense -   -   -   -  
    Income Before Tax(126,674)(88,254)(50,895)(47,894)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(126,674)(88,254)(50,895)(47,894)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (126,674) (88,254) (50,895) (47,894)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (126,674) (88,254) (50,895) (47,894)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.